Compare Bio Protocol (BIO) vs Obol (OBOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Obol — how do they compare? Bio Protocol trades at Rp516.84 (market cap Rp1,15T, Rp264,79M 24h volume), while Obol trades at Rp157.55 (market cap Rp30,1M, Rp51,72M 24h volume). The key difference: Bio Protocol is far larger — about 38206× Obol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 161,3M / 500M OBOL (33%) for Obol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Obol for 14 Days on average.
| BIO | OBOL | |
|---|---|---|
Market Cap | Rp1,15T | Rp30,1M |
Volume (24h) | Rp264,79M | Rp51,72M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 161,3M / 500M OBOL (33%) |
Typical Hold Time | 16 Days | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Obol (OBOL) is a cryptocurrency with a market capitalization of Rp30.1M and a circulating supply of 161.3 million tokens out of a maximum 500 million, indicating a 33% circulation rate. Current price data is unavailable, but the token shows limited market activity with a 14-day average hold time suggesting short-term trading. No recent protocol updates or ecosystem developments are reported, and trading volumes appear low.
The outlook for OBOL is cautious due to low liquidity and minimal market presence. Key opportunities include potential growth if ecosystem activity increases, but major risks involve high volatility, low exchange liquidity, and regulatory uncertainties common to small-cap cryptocurrencies. Investors should monitor for any network updates or exchange listings that could impact value.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Obol
Obol develops vital technologies that enhance Ethereum's decentralization and security, currently protecting billions in staked ETH. Its Distributed Validators (DVs) offer better uptime, lower risk, and improved performance compared to traditional staking. Using the middleware Charon, DVs enable Ethereum validators to function across multiple operators and machines, featuring threshold signing and distributed key generation for added resilience. The Obol Collective, powered by the OBOL Token, includes the largest decentralized operator ecosystem with major players like Lido and Blockdaemon. The Obol Stack simplifies the deployment of Ethereum nodes and other decentralized infrastructures, advancing the Ethereum economy.
Read more on OBOL →
